CCND1 and breast carcinoma: In a study by Lewis-Wambi et al. (2011), BZA combined with conjugated estrogen was shown to reduce the proliferation of estrogen receptor (ER)-positive breast cancer cells by downregulating ERα and cyclin D1 [15].